Rockefeller Capital Management’s Vaxart VXRT Stock Holding History

Rockefeller Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,175	Closed	-$429	–	4855
2025 Q3	$429	Buy	+1,175	New	+$483	﹤0.01%	4288
2021 Q3	–	Sell	-530	Closed	-$3K	–	3862
2021 Q2	$3K	Sell	530 -765	-59%	-$5.34K	﹤0.01%	3200
2021 Q1	$7K	Buy	1,295 +795	+159%	+$6.12K	﹤0.01%	2788
2020 Q4	$2K	Sell	500 -8,000	-94%	-$50.9K	﹤0.01%	2673
2020 Q3	$56K	Hold	8,500	–	–	﹤0.01%	1475
2020 Q2	$75K	Buy	+8,500	New	+$24.4K	﹤0.01%	1275

Other funds holding VXRT

HWA

Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

LCM

LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

AIC

Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return

Rockefeller Capital Management's VXRT Position: Q4 2025 in Review

Rockefeller Capital Management sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 1,175 shares — an estimated $429 sold.

Rockefeller Capital Management first reported a position in VXRT in Q2 2020 and held it in 6 quarters. The position peaked at $75K in Q2 2020. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

Rockefeller Capital Management reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
Rockefeller Capital Management sold 1,175 Vaxart shares in Q4 2025, an estimated $429.
Rockefeller Capital Management first reported a position in Vaxart in Q2 2020 and held it in 6 quarters.
Rockefeller Capital Management's Vaxart position peaked at $75K in Q2 2020.
5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on Rockefeller Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.